OSL oncosil medical ltd

Ann: OncoSil receives Swiss regulatory approval, page-47

  1. 64 Posts.
    lightbulb Created with Sketch. 15
    Hi vrs37, looking at the conditions attached to the CE mark I'd be surprised if they get many other sales. The CE limits the use of the product to use in combination with gemcitabine only as a chemotherapy. Gemcitabine alone is a very outdated treatment for this cancer. There are other, more effective chemotherapeutic agents available now, that are likely also reimbursed. So why would an oncologist suggest a patient pay out of their own pocket for a therapy that they know they can get equal or better results from that they don't have to completely cover the cost of.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.070(5.69%)
Mkt cap ! $16.49M
Open High Low Value Volume
$1.25 $1.25 $1.11 $72.36K 60.96K

Buyers (Bids)

No. Vol. Price($)
1 9286 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.18 412 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.